Australia markets closed

PetVivo Holdings, Inc. (PETV)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
2.6300+0.2600 (+10.97%)
At close: 04:00PM EDT
2.6300 0.00 (0.00%)
After hours: 05:13PM EDT

PetVivo Holdings, Inc.

5251 Edina Industrial Boulevard
Minneapolis, MN 55439
United States
952 405 6216

IndustryMedical Devices
Full-time employees2

Key executives

NameTitlePayExercisedYear born
Mr. John LaiCEO, Pres & Director91.67kN/A1962
Mr. Randall A. MeyerChief Operating Officer15.83kN/A1964
Mr. John F. DolanGen. Counsel, Chief Bus. Devel. Officer & Sec.40.25kN/A1965
Mr. Robert J. FolkesChief Financial OfficerN/AN/A1963
Mr. Gary DeMelExec. VP of Bus. Devel.N/AN/A1957
Mr. Russell SiakelDirector of MarketingN/AN/AN/A
Mr. Mark MiddletonNational Director of SalesN/AN/AN/A
Mr. Randy WentholdChief Science OfficerN/AN/AN/A
Amounts are as of 31 December 2021, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.


PetVivo Holdings, Inc., a veterinary biotech and biomedical device company, engages in the licensing and commercializing of medical devices and biomaterials for the treatment of afflictions and diseases in animals. Its lead product is Kush, a veterinarian-administered joint injection for the treatment of osteoarthritis and lameness in dogs and horses. The company's pipeline products include 17 therapeutic devices for veterinary and human clinical applications. PetVivo Holdings, Inc. is headquartered in Minneapolis, Minnesota.

Corporate governance

PetVivo Holdings, Inc.’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.